Toggle navigation
Home
Search
Services
Blog
Contact
About
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J.
Leukosite, Inc., Cambridge, MA, United States
Search 4 grants from Michael Briskin
Search grants from Leukosite, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms of Leptin Signaling in the Hypothalamus
Mycobacteriophange Interaction with M Tuberculosis
Transmission of Granulocytic Ehrlichiosis
Moclobemide in Social Phobia
Short-Term Research Training
Recently added grants:
Structural investigation of the gating and regulatory mechanism of voltage-gated Ca2+ channels
Intracellular Cholesterol Transport
Mechanisms of glucose signal transduction in yeast
Implementation Support for Prevention Program Delivery by College Peer Educators
Single synapse analysis of synaptic plasticity by combining electrophysiology and array tomography
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44DK049883-02
Application #
2016997
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (01))
Project Start
1995-06-15
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Leukosite, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Related projects
NIH 1997
R44 DK
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J. / Leukosite, Inc.
NIH 1996
R44 DK
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J. / Leukosite, Inc.
Comments
Be the first to comment on Michael Briskin's grant